
|Videos|June 14, 2022
How Decentralized Clinical Trial (DCT) Design Brings Clinical Research as a Care Option to Cancer Patients
Author(s)Thread Research
Esther Howard, Oncology Advisor at THREAD, will be shedding light on how DCT design brings clinical research as a care option to cancer patients. In 2021, over 608,000 Americans alone passed away from cancer- equating to 1,600 deaths a day. Because clinical trials become the only treatment option for cancer patients after they have exhausted all standard of care options, we desperately need solutions to bring real access to clinical trials as a care option to more cancer patients. Esther will focus on some of the challenges that patients face, and how elements of a DCT design can not only save the lives of more patients but can also be a key driver in improving diversity in enrollment.
Trending on Applied Clinical Trials Online
1
ACT Brief: Real-Time Review Ecosystem Approach, AI Infrastructure Before Tools, and FDA Peptide Compounding Access
2
Artificial Intelligence in Clinical Trials: From Pilots to Practice
3
Validity, Reliability, and Regulatory Considerations for Consumer Devices in Clinical Research Data Collection
4
FDA Finalizes Three Guidances to Broaden Cancer Clinical Trial Eligibility
5




